Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

China Health Service Market 2020: Trends, Size And Growth

The health service industry is still in the initial stage in China. Since the reform and open up in 30 years ago, relative to the development speed of national economy, the development of health service industry lags behind, and cannot adapt to the development situation and requirement of social economy in the present stage in China. Although GDP grows fast each year and investment in medical health field increases year by year, the problem of "expensive and hard to visit doctors" still are not released.

Research suggests: the unhealthiest people of 1% and the people with chronic illness of 19% cost 80% of medical health costs. The sharply rising of chronic illness and medical costs is threatening the competitiveness of enterprise and state, so, to ensure every person enjoys health, it is the first imperative that not only should we improve the "diagnosing and treatment" system facing unhealthy people, but also establish a healthy service system serving health people. Complete report available @ www.rnrmarketresearch.com/forecast-repor... .

Several elements are at work powering healthcare investment in China. With growing per capita incomes, China's quite wealthy individuals are asking for the latest in medical care and services. Simultaneously, replacing diets and air and water polluting of the environment is leading to an increase in the occurrence of cancer, heart, diabetic issues along with other chronic diseases among China's population. Both are developing new possibilities for drug manufacturing, medical equipment, hospital management and organizations that offer a wide selection of healthcare services and products.

Healthcare is among the last large market sectors in China to unlock to international investment and technology. Apart from increasing need for the best offered treatment of newly wealthy customers, China is dealing with new issues like cancer; cardiovascular disease, diabetes as well as other long-term disease problems affects more of its population. Order a copy of this research report via sending an email at sales@rnrmarketresearch.com . Order before Apr 30th, 2015 and get 10% discount on this research report.

China declared a pilot project where foreign investors are able to set up entirely foreign-funded hospitals, either by Acquisition or Greenfield in 7 of its cities and provinces. Hence, private capitals as well as major investors are positively looking for new investment possibilities in hospitals and organizations with the most recent in healthcare technology.

In 2013, the market scale of the health service was about CNY 3.54 trillion, up 21.9% over last year, almost 3 times higher than the one in 2009. Along with the increasing market scale, the growth rate of output value also increases considerably in 2013; the output value of health service industry was as high as CNY 550 billion.

It is predicted that the market scale of health service industry will hit CNY 7.92 trillion in 2020, which is consistent with the national development objective that the market scale of health service industry will reach CNY 8 trillion by 2020. Get discount on this premium research report priced at US $1900 for single user PDF license. Order a copy before Apr 30th, 2015 and get 10% discount on this report at www.rnrmarketresearch.com/contacts/disco... .

Table of Contents:

1. Overview of Health Service Industry.
2. Development of International Health Service Industry.
3. Development of Health Service Industry in China.
4. Segmentations of Health Service Industry.
5. Consumption Market of Health Service Industry.
6. Competition Pattern of Health Service Industry.
7. Key Health Service Organizations in China.
8. Development Trend Forecast of Health Service Industry.
9. Investigation on Investment Status Quo of Health Service Industry.
10.Investment Environment Forecast of Health Service Industry.
11.Investment Opportunity and Risk Evaluation of Health Service Industry.
12.Investment Strategy of Health Service Industry.

Browse Other Reports from "Huidian Research" (Buy 1 report of Huidian Research and get 25% off on the second report)

  • In-depth Research and Forecast of China's Dietary Supplement (Health Food) Industry, 2014-2018

Since 2005, China's dietary supplement industry has represented an upswing trend with the market demand increasing continuously. At 2013, the market size of China's dietary supplement industry reached CNY 186.9 billion, up by 18% over last year. And it is estimated that the market size will amount to CNY 214.9 billion, up by 15% over last year, which drops slightly due to the influence of the general environment. From the perspective of the production scale and distribution channels, China's dietary supplement industry is still in the earlier stage of the development of European and American markets. In the aspect of enterprise size, China's dietary supplement enterprises mainly are within CNY 50 million to CNY 500 million. Therefore large-sized enterprises are few and enterprises with economies of scale are also few. Complete report available @ www.rnrmarketresearch.com/in-depth-resea... .

  • Research and Investment Forecast Evaluation of China's Enteral Nutrition Preparation Market from 2015 to 2020

In China, the clinical nutrition market started in 1960s-70s. After entered into China market in 1982, China-Germany joint venture Sino-Swed Pharmaceutical is the first enterprise launching fat emulsion, amino acid and other products into market. With tens of years of development, the market is segmented increasingly, each variety increases rapidly. In recent years, with the popularization of clinical nutrition conception in China, more and more domestic enterprises set foot in this field. According to statistics, in 2010, the market scale of enteral nutrition preparation was CNY 2.21 billion in China, by the end of 2014; it was CNY 4.11 billion and increases continually. Complete report available @ www.rnrmarketresearch.com/research-and-i... .

Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.